Clinical Neurological Society of America

#DYK? #CAE is usually diagnosed in otherwise healthy and normally developing children when they are between the ages of 4 and 10. Learn more: bit.ly/4bvco3l

Psychotic symptoms in Alzheimer’s disease can occur at any point during the illness, though they may be more severe later in the disease. Learn more: bit.ly/3Srejgl

#StatusEpilepticus is a condition of prolonged seizures, abnormal excessive or synchronous neural activity in the brain that can result in brain injury and death. Read more: bit.ly/3XleZYV

#ICYMI: Episode 2 of the six-part series, "Alzheimer's Disease: Fro Pre-Diagnosis to Treatment to What's Next," presented by Raymod Scott Turner, MD, PhD, is out NOW! Watch episode: bit.ly/43d0QR7

With the growing prevalence of age-related neurodegenerative conditions such as #Alzheimer’s and #Parkinson’s, the prevalence of #PBA is expected to increase over time. Read more: bit.ly/3WMwz5Y

#ICYMI: Episode 3 of the six-part series, "Alzheimer's Disease: Fro Pre-Diagnosis to Treatment to What's Next," presented by Marwan Noel Sabbagh, MD, is out NOW! Watch episode: bit.ly/4kcx2ZM

CNSA's latest episode of its Alzheimer's disease 6-part series is now LIVE! Listen to @SuzanneESchind1, MD, PhD, as she talks about the realities of treating Alzheimer’s Disease from a clinician's experience. Watch to learn more: bit.ly/3TYEddH

#DYK? #RettSyndrome is a rare neurodevelopmental disorder that occurs almost exclusively in females. Learn more: bit.ly/3pWaUwJ

#Synucleinopathies are difficult to recognize because many of their symptoms are similar to those of other diseases, resulting in delayed treatment and prolonged patient suffering. Read more: bit.ly/4jrpfbh

#ICYMI: Episode 4 of the six-part series, "Alzheimer's Disease: Fro Pre-Diagnosis to Treatment to What's Next," presented by Irina Anna Skylar-Scott, MD, is out NOW! Watch episode: bit.ly/3I1vJzw

Save the date for Contemporary Neurology 2026, January 17-20, 2026 at the Jupiter Beach Resport & Spa. Learn more: bit.ly/427TbSg

Interested in becoming a member of CNSA? CNSA's mission is to improve clinical practice and patient care through education and thought leadership. Join or renew here: bit.ly/3okHSCl

The CIDP Ambassador Program, a collaboration between CNSA and Grifols, is an educational program on improving the recognition, diagnosis and treatment of #CIDP. Learn more: bit.ly/4eCLsR3

#ICYMI: Episode 1 of the 6-part series "Alzheimer's Disease: From Pre-diagnosis to Treatment to What's Next," is out now! Watch to learn more about #Alzheimers pre-diagnosis: bit.ly/3St4obx

DYK? Psychosis affects approximately 30-40% of Alzheimer's disease patients. Learn more in CNSA's webinar recording: bit.ly/42BXXJs

#DYK? Fully formed silent visual hallucinations — such as seeing a person or animal — are the most common hallucinatory events in Alzheimer’s disease. Read more in CNSA's white paper: bit.ly/3Srejgl

Caregiver support is extremely important in Alzheimer's disease however, race, ethnicity, geographic location and socioeconomic status play a major role in the availability for care and support services. Read more: bit.ly/3YSNTs9

#ICYMI: Episode 2 of the six-part series "Alzheimer's Disease: From Pre-diagnosis to Treatment to What's Next," presented by Scott R. Turner, MD, PhD, is out NOW! Watch episode: bit.ly/4jwuab1

DYK? CNSA has TWO upcoming clinical proceedings on topics ranging from epilepsy to acute intermittent porphyria. View CNSA's Clinical Proceedings series here ▶️ bit.ly/3a2xoEh

#DYK? Often, the first sign of Alzheimer’s disease is memory loss, especially involving recently learned information. Read more in CNSA's white paper: bit.ly/3YSNTs9